RxDoctor Payments Data

Kenneth Eugene, MD

Family Medicine · Rincon, GANPI 1801950530

Payments from drug & device makers

$2,680in general payments, 2019–2025

Across 162 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$555
  • Novo Nordisk$471
  • Pfizer$320
  • AstraZeneca$271
  • Boehringer Ingelheim$179
  • Amgen$164
  • plus $720 from 20 others

What the payments were for

  • Food & beverage$2,680100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,680 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$105,371
Medicare patients
273
Services billed
1,777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$160,573
RybelsusSemaglutide99$154,254
MounjaroTirzepatide63$98,706
JardianceEmpagliflozin60$81,849
EliquisApixaban69$73,493
FarxigaDapagliflozin Propanediol65$71,715
TrulicityDulaglutide47$58,588
LinzessLinaclotide27$30,155
JanuviaSitagliptin Phosphate16$19,029
Tresiba Flextouch U-100Insulin Degludec15$15,704
XareltoRivaroxaban17$13,477
TradjentaLinagliptin11$11,773
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$9,321
GemtesaVibegron21$5,799
Novolog FlexpenInsulin Aspart18$4,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$471$314,827212 claims
Lilly USA, LLCMounjaro, Trulicity$555$157,294110 claims
Boehringer IngelheimJardiance, Tradjenta$179$93,62271 claims
PfizerEliquis$320$73,49369 claims
AstraZenecaFarxiga$271$71,71565 claims
AbbVieLinzess$65$30,15527 claims
MerckJanuvia$14$19,02916 claims
Sumitomo Pharma America, Inc.Gemtesa$59$5,79921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Rincon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →